Skip to main content

Chemoprevention: Progress And Opportunity

  • Chapter
Nutrition and Cancer Prevention

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 492))

  • 443 Accesses

Abstract

A generally accepted definition of chemoprevention is the administration of purified chemical agents for the prevention of clinical cancer. This concept is commonly thought to have emerged a little over two decades ago and is attributed to cancer biologists who were elucidating the role of various natural substances and pharmacologic agents on the stepwise progression of cancer.26 However, a brief review of public health and medical advances over the twentieth century will reveal that the concept and application of chemoprevention for various disease processes evolved directly from the great successes of nutritional scientists in the early decades of this century. Regardless of the conceptual origins of cancer chemoprevention, the progress in identifying agents, testing them in preclinical models, followed by human intervention studies, has rapidly accelerated in recent years. The century ends with the success of the Breast Cancer Prevention Trial (BCPT) illustrating the ability of the anti-estrogen Tamoxifen to prevent breast cancer in a cohort of women at high-risk.10 Indeed, it is our opinion that chemoprevention, tobacco control, and the application of early detection strategies provide the opportunity to reduce cancer mortality by at least 50% within a generation.11 The objective of this review is to provide the broad audience of cancer prevention investigators with a brief overview of the progress and future promise of cancer chemoprevention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Institute for Cancer Research. Food Nutrition and the Prevention of Cancer: a Global Perspective Washington, DC: American Institute for Cancer Research 1997.

    Google Scholar 

  2. Anonymous. Iodine fortification and thyrotoxicosis. Nutr Rev 1970;28:212–214.

    Google Scholar 

  3. Anonymous. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992; 41:1–7.

    Google Scholar 

  4. Austin H, Keil JE, Cole P. A prospective follow-up study of cancer mortality in relation to serum DDT. Am J Public Health 1989; 79:43–46.

    Article  PubMed  CAS  Google Scholar 

  5. Bentley JR, Ferrini RL, Hill LL. American College of Preventive Medicine Public Policy Statement: Folic acid fortification of grain products in the U.S. to prevent neural tube defects. Am J Prey Med 1999;16:264–267.

    Article  CAS  Google Scholar 

  6. Berry Rj, Li Z, Erickson JD, Li S, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485–1490.

    Article  Google Scholar 

  7. Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 1998;56: 35–51.

    Article  PubMed  CAS  Google Scholar 

  8. de la Chapelle A, Peltomaki P. Genetics of hereditary colon cancer. Annu Rev Genet 1995;29:329–348.

    Article  PubMed  Google Scholar 

  9. de la Chapelle A, Peltomaki P. The genetics of hereditary common cancers. Curr Opin Genet Dev 1998;8:298–303.

    Article  PubMed  Google Scholar 

  10. Fisher B, Costantino JP, Wickerham DL, Redmond CK, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371–1388.

    Article  PubMed  CAS  Google Scholar 

  11. Greenwald P, Kramer BS, Weed DL, eds. Cancer Prevention and Control. New York, NY: Marcel Dekker, 1995.

    Google Scholar 

  12. Hoar SK, Blair A, Holmes FF, Boysen CD, et al. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA 1986;256:1141–1147.

    Article  PubMed  CAS  Google Scholar 

  13. Holland JF, Bast RC, Morton DL, Frei E, et al. Cancer Medicine 4 th edition , Baltimore, MD: Williams and Wilkins, 1997.

    Google Scholar 

  14. Hollick MF, Shao Q, Liu WW, Chen TC. The vitamin D content of fortified milk and infant formula. N Engl J Med 1992; 326:1178–1181.

    Article  Google Scholar 

  15. Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 1997; 13:291–298.

    Article  PubMed  CAS  Google Scholar 

  16. Kelloff GJ, Malone WF, Boone CW, Steele VE, Doody LA. Intermediate biomarkers of precancer and their application in chemoprevention. J Cell Biochem - Supplement 1992;16G:15–21.

    Article  CAS  Google Scholar 

  17. Kimball OP, Marine D. The prevention of simple goiter in man. Arch Inst Med 1918; 22:41.

    Article  CAS  Google Scholar 

  18. Lee K, Bradley R, Dwyer J, Lee SL. Too much versus too little: the implications of current iodine intake in the United States. Nutr Rev 1999;57:177–181.

    Article  PubMed  CAS  Google Scholar 

  19. Liotta LA. Probing the depths of degradation: matrix metaloproteinase-2 and endometrial menstrual breakdown. J Clin Invest 1996;97:273–274.

    Article  PubMed  CAS  Google Scholar 

  20. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999;12:351–366.

    PubMed  CAS  Google Scholar 

  21. Mertz W. Food fortification in the United States. Nutr Rev 1997; 55:44–49.

    Article  PubMed  CAS  Google Scholar 

  22. Mukherjee P, Sotnikov AV, Mangian HJ, Zhou J. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 1999;91:512–523.

    Article  PubMed  CAS  Google Scholar 

  23. Schottenfield D, Fraumeni Jr. JF. Cancer Epidemiology and Prevention, New York, NY: Oxford University Press, 1996.

    Google Scholar 

  24. Sizer FS, Whitney EN. “The Vitamins” In: Nutrition Concepts and Controversies 7 th edition, Belmont, CA: West Wadsworth, 1997.

    Google Scholar 

  25. Solon FS, Fernandez TL, Latham MC, Popkin BM. Planning, implementation, and evaluation of a fortification program. Control of vitamin A deficiency in the Philippines. J Am Diet Assoc 1979;74:112–118.

    PubMed  CAS  Google Scholar 

  26. Sporn MB. Combination chemoprevention of cancer. Nature 1980;287:107–108.

    Article  PubMed  CAS  Google Scholar 

  27. Tinger A, Wasserman TH, Klein EE, Miller EA, et al. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys 1997; 37:865–870.

    Article  PubMed  CAS  Google Scholar 

  28. Toro O, de Pablo S, Aguayo M, Gattan V, et al. Prevention of vitamin A deficiency by fortification of sugar. A field study. Arch Latinoam Nutr 1977;27:169–179.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Miller, E.C., Liao, Z., Guo, Y., Shah, S.M., Clinton, S.K. (2001). Chemoprevention: Progress And Opportunity. In: Nutrition and Cancer Prevention. Advances in Experimental Medicine and Biology, vol 492. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1283-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1283-7_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5477-2

  • Online ISBN: 978-1-4615-1283-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics